JP2017052962A5 - - Google Patents

Download PDF

Info

Publication number
JP2017052962A5
JP2017052962A5 JP2016214773A JP2016214773A JP2017052962A5 JP 2017052962 A5 JP2017052962 A5 JP 2017052962A5 JP 2016214773 A JP2016214773 A JP 2016214773A JP 2016214773 A JP2016214773 A JP 2016214773A JP 2017052962 A5 JP2017052962 A5 JP 2017052962A5
Authority
JP
Japan
Prior art keywords
group
aminooxy
oligosaccharide
reactive group
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016214773A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017052962A (ja
JP6309592B2 (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2017052962A publication Critical patent/JP2017052962A/ja
Publication of JP2017052962A5 publication Critical patent/JP2017052962A5/ja
Application granted granted Critical
Publication of JP6309592B2 publication Critical patent/JP6309592B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016214773A 2007-01-18 2016-11-02 アミノオキシ基を含むオリゴ糖およびその複合体 Active JP6309592B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US88547107P 2007-01-18 2007-01-18
US60/885,471 2007-01-18

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2014204593A Division JP6039625B2 (ja) 2007-01-18 2014-10-03 アミノオキシ基を含むオリゴ糖およびその複合体

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018044959A Division JP2018109194A (ja) 2007-01-18 2018-03-13 アミノオキシ基を含むオリゴ糖およびその複合体

Publications (3)

Publication Number Publication Date
JP2017052962A JP2017052962A (ja) 2017-03-16
JP2017052962A5 true JP2017052962A5 (cg-RX-API-DMAC7.html) 2017-06-08
JP6309592B2 JP6309592B2 (ja) 2018-04-11

Family

ID=39473250

Family Applications (7)

Application Number Title Priority Date Filing Date
JP2009546533A Active JP5999867B2 (ja) 2007-01-18 2008-01-18 アミノオキシ基を含むオリゴ糖およびその複合体
JP2014204593A Active JP6039625B2 (ja) 2007-01-18 2014-10-03 アミノオキシ基を含むオリゴ糖およびその複合体
JP2016214773A Active JP6309592B2 (ja) 2007-01-18 2016-11-02 アミノオキシ基を含むオリゴ糖およびその複合体
JP2018044959A Pending JP2018109194A (ja) 2007-01-18 2018-03-13 アミノオキシ基を含むオリゴ糖およびその複合体
JP2020134331A Pending JP2020185011A (ja) 2007-01-18 2020-08-07 アミノオキシ基を含むオリゴ糖およびその複合体
JP2022113593A Pending JP2022137232A (ja) 2007-01-18 2022-07-15 アミノオキシ基を含むオリゴ糖およびその複合体
JP2024207922A Pending JP2025029023A (ja) 2007-01-18 2024-11-29 アミノオキシ基を含むオリゴ糖およびその複合体

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2009546533A Active JP5999867B2 (ja) 2007-01-18 2008-01-18 アミノオキシ基を含むオリゴ糖およびその複合体
JP2014204593A Active JP6039625B2 (ja) 2007-01-18 2014-10-03 アミノオキシ基を含むオリゴ糖およびその複合体

Family Applications After (4)

Application Number Title Priority Date Filing Date
JP2018044959A Pending JP2018109194A (ja) 2007-01-18 2018-03-13 アミノオキシ基を含むオリゴ糖およびその複合体
JP2020134331A Pending JP2020185011A (ja) 2007-01-18 2020-08-07 アミノオキシ基を含むオリゴ糖およびその複合体
JP2022113593A Pending JP2022137232A (ja) 2007-01-18 2022-07-15 アミノオキシ基を含むオリゴ糖およびその複合体
JP2024207922A Pending JP2025029023A (ja) 2007-01-18 2024-11-29 アミノオキシ基を含むオリゴ糖およびその複合体

Country Status (21)

Country Link
US (6) US8759501B2 (cg-RX-API-DMAC7.html)
EP (5) EP2457919B1 (cg-RX-API-DMAC7.html)
JP (7) JP5999867B2 (cg-RX-API-DMAC7.html)
CN (2) CN101631794B (cg-RX-API-DMAC7.html)
CA (1) CA2675968C (cg-RX-API-DMAC7.html)
CY (2) CY1119954T1 (cg-RX-API-DMAC7.html)
DK (3) DK2457920T3 (cg-RX-API-DMAC7.html)
ES (3) ES2417146T3 (cg-RX-API-DMAC7.html)
FI (1) FIC20220047I1 (cg-RX-API-DMAC7.html)
FR (1) FR22C1061I2 (cg-RX-API-DMAC7.html)
HR (3) HRP20130744T1 (cg-RX-API-DMAC7.html)
HU (3) HUE036140T2 (cg-RX-API-DMAC7.html)
IL (3) IL243117B2 (cg-RX-API-DMAC7.html)
LT (3) LT2457919T (cg-RX-API-DMAC7.html)
LU (1) LUC00290I2 (cg-RX-API-DMAC7.html)
NL (1) NL301210I2 (cg-RX-API-DMAC7.html)
NO (2) NO2457920T3 (cg-RX-API-DMAC7.html)
PL (3) PL2121713T3 (cg-RX-API-DMAC7.html)
PT (3) PT2457920T (cg-RX-API-DMAC7.html)
SI (2) SI2457920T1 (cg-RX-API-DMAC7.html)
WO (1) WO2008089403A2 (cg-RX-API-DMAC7.html)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7723296B2 (en) 2001-01-18 2010-05-25 Genzyme Corporation Methods for introducing mannose-6-phosphate and other oligosaccharides onto glycoproteins and its application thereof
US8795680B2 (en) * 2006-07-21 2014-08-05 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methods for conjugation of oligosaccharides or polysaccharides to protein carriers through oxime linkages via 3-deoxy-D-manno-octulsonic acid
WO2008089403A2 (en) * 2007-01-18 2008-07-24 Genzyme Corporation Oligosaccharides comprising an aminooxy group and conjugates thereof
CA2696699A1 (en) * 2007-08-20 2009-02-26 Protalix Ltd. Saccharide-containing protein conjugates and uses thereof
CN102369023A (zh) * 2008-12-16 2012-03-07 建新公司 寡糖-蛋白缀合物
US8962573B2 (en) 2009-07-03 2015-02-24 Inserm (Institut National De La Sante Et De La Recherche Medicale) Compounds targeting the cation-independent mannose 6-phosphate receptor
JP5909755B2 (ja) 2009-07-27 2016-04-27 リポクセン テクノロジーズ リミテッド 非血液凝固タンパク質の糖ポリシアル酸化
EP3093029A1 (en) * 2009-07-27 2016-11-16 Baxalta GmbH Blood coagulation protein conjugates
US9194011B2 (en) 2009-11-17 2015-11-24 Protalix Ltd. Stabilized alpha-galactosidase and uses thereof
EP2585108A4 (en) * 2010-06-24 2016-04-13 Univ Kansas CONJUGATES WITH AN N-OXIM BINDING AND ASSOCIATED METHODS
WO2012082635A1 (en) * 2010-12-13 2012-06-21 Ancora Pharmaceuticals, Inc. Synthetic oligosaccharide group a streptococcus
KR101883803B1 (ko) 2011-01-20 2018-07-31 프로탈릭스 리미티드 식물 및 식물 세포에서 알파-갈락토시다제의 발현용 핵산 작제물
AU2014218854B2 (en) 2013-02-20 2019-01-24 Valerion Therapeutics, Llc Methods and compositions for treatment of Pompe disease
GB201508025D0 (en) 2015-05-11 2015-06-24 Ucl Business Plc Fabry disease gene therapy
KR20250007693A (ko) 2015-12-30 2025-01-14 아미쿠스 세라퓨틱스, 인코포레이티드 폼페병 치료용의 강화된 산 알파-글루코시다제
SMT202300187T1 (it) 2017-05-15 2023-07-20 Amicus Therapeutics Inc Alfa-glucosidasi acida umana ricombinante
TWI821227B (zh) 2017-12-22 2023-11-11 美商健臻公司 胺甲喋呤誘發的免疫耐受性之生物標記
SG11202100928QA (en) 2018-08-02 2021-02-25 Dyne Therapeutics Inc Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy
US12018087B2 (en) 2018-08-02 2024-06-25 Dyne Therapeutics, Inc. Muscle-targeting complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide and methods of delivering oligonucleotide to a subject
CA3118909A1 (en) * 2018-11-08 2020-05-14 Kaleido Biosciences, Inc. Oligosaccharide compositions and methods of use thereof
WO2021156792A1 (en) 2020-02-07 2021-08-12 Novartis Ag Targeted plasma protein degradation
MX2022009753A (es) * 2020-02-08 2022-09-07 Genzyme Corp Composiciones y metodos para el tratamiento de la enfermedad de pompe.
EP4164678A1 (en) 2020-06-14 2023-04-19 Genzyme Corporation Compositions and methods for treating late-onset pompe disease

Family Cites Families (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4701521A (en) * 1978-07-17 1987-10-20 The Trustees Of Boston University Method of effecting cellular uptake of molecules
DE2940845B1 (de) 1979-10-09 1980-06-26 Ford Werke Ag Kreiselpumpendichtung,insbesondere fuer Kuehlwasserpumpen in Kraftfahrzeugen
US4671958A (en) * 1982-03-09 1987-06-09 Cytogen Corporation Antibody conjugates for the delivery of compounds to target sites
US5066789A (en) * 1988-09-30 1991-11-19 Neorx Corporation Targeting substance-diagnostic/therapeutic agent conjugates having Schiff base linkages
IL93432A (en) 1989-02-24 1994-02-27 Johnson Mathey Inc Hydrazines and hydrazides, their conjugates with macromolecules and such conjugates labelled with metal ions
US5206370A (en) * 1989-02-24 1993-04-27 Johnson Matthey, Inc. Certain pyridyl hydrazines and hydrazides useful for protein labeling
US5212298A (en) * 1989-08-16 1993-05-18 Monsanto Company Method for producing synthetic N-linked glycoconjugates
US5280113A (en) * 1989-08-16 1994-01-18 Monsanto Company Method for producing synthetic N-linked glycoconjugates
US5324663A (en) * 1990-02-14 1994-06-28 The Regents Of The University Of Michigan Methods and products for the synthesis of oligosaccharide structures on glycoproteins, glycolipids, or as free molecules, and for the isolation of cloned genetic sequences that determine these structures
US5583042A (en) * 1990-04-16 1996-12-10 Neose Pharmaceuticals, Inc. Apparatus for the synthesis of saccharide compositions
US5153312A (en) * 1990-09-28 1992-10-06 American Cyanamid Company Oligosaccharide conjugate vaccines
EP0513332A4 (en) * 1990-11-14 1993-03-17 Cargill, Incorporated Conjugates of poly(vinylsaccharide) with proteins for the stabilization of proteins
AU1580292A (en) * 1991-03-13 1992-10-21 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Increasing the therapeutic efficiency of macrophage-targeted therapeutic agents by up-regulating the mannose lectin on macrophages
JPH06506217A (ja) 1991-03-18 1994-07-14 エンゾン，インコーポレーテッド ポリペプチドまたはグリコポリペプチドとポリマーとのヒドラジン含有結合体
FR2721612B1 (fr) * 1994-06-23 1996-08-09 Idm Nouveaux dérivés d'oligosides, leur procédé de préparation et leurs applications.
US6132764A (en) * 1994-08-05 2000-10-17 Targesome, Inc. Targeted polymerized liposome diagnostic and treatment agents
US6071890A (en) 1994-12-09 2000-06-06 Genzyme Corporation Organ-specific targeting of cationic amphiphile/DNA complexes for gene therapy
US6118045A (en) * 1995-08-02 2000-09-12 Pharming B.V. Lysosomal proteins produced in the milk of transgenic animals
AUPO190596A0 (en) * 1996-08-26 1996-09-19 Alchemia Pty Ltd Oligosaccharide synthesis
US6472506B1 (en) * 1997-01-21 2002-10-29 Aventis Pasteur S.A. Polysaccharide-peptide-conjugates
US5952516A (en) 1997-05-08 1999-09-14 Genzyme Corporation Cationic amphiphiles containing multiplesteroid lipophilic groups
IL135578A0 (en) 1997-10-29 2001-05-20 Genzyme Corp Compositions and methods for treating lysosomal storage disease
US6287857B1 (en) 1998-02-09 2001-09-11 Genzyme Corporation Nucleic acid delivery vehicles
US6538117B1 (en) * 1999-08-10 2003-03-25 The Scripps Research Institute Programmable one-pot oligosaccharide synthesis
DE69941574D1 (de) * 1998-08-19 2009-12-03 Baxter Healthcare Sa Immunogenes beta-propionamido-gebundenes polysaccharid-protein konjugat geeignet als impfstoff und hergestellt bei verwendung von n-acryloyliertem polysaccharid
US6399575B1 (en) * 1998-11-10 2002-06-04 Auburn University Methods and compositions for targeting compounds to the central nervous system
EP1035137A1 (en) 1999-03-12 2000-09-13 Pasteur Merieux Serums Et Vaccins Method for the reductive amination of polysaccharides
CN1762990A (zh) 1999-06-08 2006-04-26 拉卓拉药物公司 包含氨基氧基的化合价平台分子
US6770468B1 (en) * 1999-09-14 2004-08-03 Genzyme Glycobiology Research Institute, Inc. Phosphodiester-α-GlcNAcase of the lysosomal targeting pathway
US6534300B1 (en) * 1999-09-14 2003-03-18 Genzyme Glycobiology Research Institute, Inc. Methods for producing highly phosphorylated lysosomal hydrolases
EP1263472A2 (en) 2000-02-15 2002-12-11 Genzyme Corporation Modification of biopolymers for improved drug delivery
US6749865B2 (en) * 2000-02-15 2004-06-15 Genzyme Corporation Modification of biopolymers for improved drug delivery
WO2002007671A2 (en) 2000-07-26 2002-01-31 Ramot-University Authority For Applied Research And Industrial Development Ltd. Intracellular delivery system for protein phosphatases and other polypeptides
AU8653901A (en) * 2000-08-18 2002-03-04 Massachusetts Inst Technology Apparatus and methods for the automated synthesis of oligosaccharides
US6676963B1 (en) * 2000-10-27 2004-01-13 Barnes-Jewish Hospital Ligand-targeted emulsions carrying bioactive agents
US7001994B2 (en) * 2001-01-18 2006-02-21 Genzyme Corporation Methods for introducing mannose 6-phosphate and other oligosaccharides onto glycoproteins
US7723296B2 (en) 2001-01-18 2010-05-25 Genzyme Corporation Methods for introducing mannose-6-phosphate and other oligosaccharides onto glycoproteins and its application thereof
US7560424B2 (en) * 2001-04-30 2009-07-14 Zystor Therapeutics, Inc. Targeted therapeutic proteins
WO2002087510A2 (en) * 2001-04-30 2002-11-07 Symbiontics, Inc. Subcellular targeting of therapeutic proteins
US7629309B2 (en) * 2002-05-29 2009-12-08 Zystor Therapeutics, Inc. Targeted therapeutic proteins
EP1385873A2 (en) 2001-05-07 2004-02-04 Supratek Pharma, Inc. A ligand for enhancing oral and cns delivery of biological agents
EP2067775B1 (en) * 2001-07-16 2012-04-25 Genzyme Corporation A N-Acylsphingosine glucosyltransferase inhibitor
US7265084B2 (en) * 2001-10-10 2007-09-04 Neose Technologies, Inc. Glycopegylation methods and proteins/peptides produced by the methods
ES2411007T3 (es) 2001-10-10 2013-07-04 Novo Nordisk A/S Remodelación y glicoconjugación de péptidos
AU2002348261A1 (en) 2001-11-26 2003-06-10 Genzyme Corporation Diastereoselective synthesis of udp-glucose : n-acylsphingosine glucosyltransferase inhibitors
US6905856B2 (en) * 2001-12-21 2005-06-14 Genzyme Glycobiology Research Institute, Inc. Soluble GlcNAc phosphotransferase
US6800472B2 (en) * 2001-12-21 2004-10-05 Genzyme Glycobiology Research Institute, Inc. Expression of lysosomal hydrolase in cells expressing pro-N-acetylglucosamine-1-phosphodiester α-N-acetyl glucosimanidase
WO2003057179A2 (en) 2002-01-11 2003-07-17 Biomarin Pharmaceutical, Inc. Use of p97 as an enzyme delivery system for the delivery of therapeutic lysosomal enzymes
TWI295483B (en) 2002-01-31 2008-04-01 Sumitomo Chemical Co 3-5 group compound semiconductor, process for producing the same, and compound semiconductor element using the same
WO2003070823A2 (en) * 2002-02-20 2003-08-28 The General Hospital Corporation Conjugates comprising a biodegradable polymer and uses therefor
US6916802B2 (en) 2002-04-29 2005-07-12 Genzyme Corporation Amino ceramide-like compounds and therapeutic methods of use
EP1400533A1 (en) * 2002-09-11 2004-03-24 Fresenius Kabi Deutschland GmbH HASylated polypeptides, especially HASylated erythropoietin
BR0314227A (pt) 2002-09-11 2005-10-25 Fresenius Kabi De Gmbh Derivados de amido de hidroxialquila
US20050026823A1 (en) * 2003-06-20 2005-02-03 Biomarin Pharmaceutical Inc. Use of the chaperone receptor-associated protein (RAP) for the delivery of therapeutic compounds to the brain and other tissues
EP1638605B1 (en) 2003-06-20 2014-01-08 Raptor Pharmaceutical, Inc. Delivery of therapeutic compounds to the brain and other tissues
WO2005014049A2 (en) 2003-08-08 2005-02-17 Novo Nordisk A/S Synthesis and application of new structural well defined branched polymers as conjugating agents for peptides
ES2294535T3 (es) 2003-08-12 2008-04-01 Lipoxen Technologies Limited Derivados del acido polisialico.
US7442372B2 (en) 2003-08-29 2008-10-28 Biomarin Pharmaceutical Inc. Delivery of therapeutic compounds to the brain and other tissues
EP1525890A1 (en) 2003-10-02 2005-04-27 Complex Biosystems GmbH Protein-Proteophore complexes
US7176185B2 (en) * 2003-11-25 2007-02-13 Tsrl, Inc. Short peptide carrier system for cellular delivery of agent
CA2556169C (en) * 2004-01-29 2011-11-22 Andrew Lees Use of amino-oxy functional groups in the preparation of vaccines
US20080014188A1 (en) 2004-02-06 2008-01-17 Zankel Todd C Manufacture of Highly Phosphorylated Lysosomal Enzymes and Uses Thereof
WO2005094874A1 (en) 2004-04-01 2005-10-13 Zymenex A/S Medical use of alpha-mannosidase
US8017151B2 (en) * 2004-09-07 2011-09-13 Board Of Regents Of The University Of Nebraska By And Behalf Of The University Of Nebraska Medical Center Amphiphilic polymer-protein conjugates and methods of use thereof
EP1877099B1 (en) 2005-04-06 2012-09-19 Genzyme Corporation Therapeutic conjugates comprising a lysosomal enzyme, polysialic acid and a targeting moiety
WO2008089403A2 (en) 2007-01-18 2008-07-24 Genzyme Corporation Oligosaccharides comprising an aminooxy group and conjugates thereof
WO2008089339A2 (en) 2007-01-18 2008-07-24 Genzyme Corporation Oligosaccharide conjugates for cellular targeting
CN102369023A (zh) * 2008-12-16 2012-03-07 建新公司 寡糖-蛋白缀合物

Similar Documents

Publication Publication Date Title
JP2017052962A5 (cg-RX-API-DMAC7.html)
JP2016503799A5 (cg-RX-API-DMAC7.html)
JP2022088416A5 (cg-RX-API-DMAC7.html)
JP2015534996A5 (cg-RX-API-DMAC7.html)
JP2016204383A5 (cg-RX-API-DMAC7.html)
JP2019513770A5 (cg-RX-API-DMAC7.html)
JP2009515988A5 (cg-RX-API-DMAC7.html)
JP2017001031A5 (cg-RX-API-DMAC7.html)
RU2010144823A (ru) Гетероциклические ингибиторы мек и способы их применения
JP2017535614A5 (cg-RX-API-DMAC7.html)
JP2018516238A5 (cg-RX-API-DMAC7.html)
JP2018519245A5 (cg-RX-API-DMAC7.html)
SI2934145T1 (en) Histone demethylase inhibitors
JP2013523756A5 (cg-RX-API-DMAC7.html)
JP2017501197A5 (cg-RX-API-DMAC7.html)
RU2015148258A (ru) Силоксановое соединение и способ его получения
JP2014526533A5 (cg-RX-API-DMAC7.html)
RU2019103265A (ru) Способы получения 4-алкокси-3-(ацил или алкил)оксипиколинамидов
JP2015528013A5 (cg-RX-API-DMAC7.html)
JP2019500374A5 (cg-RX-API-DMAC7.html)
JP2015044989A5 (cg-RX-API-DMAC7.html)
JP2014167003A5 (cg-RX-API-DMAC7.html)
RU2018100967A (ru) Способ получения азотсодержащего гетероциклического соединения и его промежуточного соединения
JP2018501266A5 (cg-RX-API-DMAC7.html)
FI3601262T3 (fi) Prosessi sulfonamidirakenteisen kinaasi-inhibiittorin valmistamiseksi